{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:42:21Z","timestamp":1791294141677,"version":"4.1.0"},"reference-count":25,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T00:00:00Z","timestamp":1304640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>This study was sought to evaluate the efficacy and durability of sacral neuromodulation in the treatment of bladder pain syndrome (BPS) patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective chart review was performed of patients who had unilateral sacral nerve stimulator (InterStim\u00ae) for refractory BPS between June 2002 and December 2004. Patients were qualified for permanent implantation by showing \u226550% improvement in their bladder pain and voiding symptoms 1\u2010week post\u2010percutaneous nerve evaluation (PNE). Voiding diary was completed at pre\u2010implantation, 1 year, and on the last visit. Urinary distress inventory short form was completed pre\u2010implantation and on the last visit. Bladder pain was evaluated by visual analogue scale. Primary outcome was improvement in bladder pain. Differences among groups were compared by one\u2010way ANOVA and <jats:italic>t<\/jats:italic>\u2010test. Statistical significance was set at <jats:italic>P<\/jats:italic>\u2009\u2264\u20090.05.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty\u2010one female patients diagnosed with BPS had PNE; 11 patients (52%) showed \u226550% improvement in their bladder pain and voiding symptoms and they consider candidates for permanent implantation (Table <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#tbl1\">I<\/jats:ext-link>), while 10 patients (48%) failed to show 50% improvement in their voiding symptoms or bladder pain (Table <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#tbl2\">II<\/jats:ext-link>). In those 11 patients who underwent permanent implantation, the average patient's age was 44.3\u2009\u00b1\u20098.9 years; average time since diagnosis was 3 \u00b10.8 years; the average follow\u2010 up was 71.5\u2009\u00b1\u20099.3 months (Table <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#tbl3\">III<\/jats:ext-link>). There was significant improvement in the bladder pain and voiding parameters at 1\u2010year follow\u2010up, which was maintained at 5\u2010year follow\u2010up. There was continuous improvement in urgency (1.2\u2009\u00b1\u20090.68) at 1\u2010year follow\u2010up, and (0.98\u2009\u00b1\u20090.72) at the last visit. Average voided volume was also continuously improved from 242\u2009\u00b1\u200962.7\u2009ml at 1\u2010year follow\u2010up to 276\u2009\u00b1\u200964.7\u2009ml on the last visit.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Sacral neuromodulation as part of multimodal treatment provides an effective long\u2010term treatment option for sub\u2010group of refractory BPS. Neurourol. Urodynam. 30:1271\u20131275, 2011. \u00a9 2011 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/nau.21037","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T14:05:38Z","timestamp":1304690738000},"page":"1271-1275","source":"Crossref","is-referenced-by-count":59,"title":["Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: Long\u2010term follow\u2010up"],"prefix":"10.1002","volume":"30","author":[{"given":"Yahya Q.","family":"Ghazwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Elkelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy M.","family":"Hassouna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,6]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.10052"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01123-2"},{"key":"e_1_2_8_4_2","first-page":"112","article-title":"Interstitial cystitis: Characterization and management of an enigmatic urologic syndrome","volume":"4","author":"Nickel JC","year":"2002","journal-title":"Rev Urol"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65665-0"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68010-X"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-003-1080-1"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.08.1108"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1998.00507.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(03)00005-0"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2004.10.001"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.07.032"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.07.030"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)66551-2"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000053863.96967.5a"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.10.032"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.08.142"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2000.00559.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5905"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00476-3"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.06.039"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e31819d1319"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200204000-00003"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.10.062"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.09.071"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64292-9"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.21037","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.21037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:21:14Z","timestamp":1696897274000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.21037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,6]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1002\/nau.21037"],"URL":"https:\/\/doi.org\/10.1002\/nau.21037","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"value":"0733-2467","type":"print"},{"value":"1520-6777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,6]]}}}